Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J. Davies, John B. Buse, Vanita R. Aroda et al.|Diabetes Care|2022Cited by 1.9k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Jennifer B. Green et al.|The Lancet|2018Cited by 1.8k
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Melanie J. Davies, John B. Buse, Vanita R. Aroda et al.|Diabetologia|2022Cited by 986
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes OrganizationsFrancesco Rubino, Bruce M. Wolfe, Nizar Albache et al.|Diabetes Care|2016Cited by 969
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretionCharlotte Ling, Stefano Del Prato|Diabetologia|2008Cited by 490